COVID-19疫情期间急性缺血性卒中患者区域机械取栓影像方案
本研究回顾性分析2020年4月14日至5月21日期间转诊至区域神经科学中心考虑机械取栓的49例急性缺血性卒中患者,评估在标准头部CT和CT血管造影基础上增加胸部CT筛查COVID-19的可行性和中期结局。结果显示胸部CT诊断COVID-19的敏感度为100%、特异度为74.1%、阴性预测值为100%、阳性预测值为22.2%,额外耗时184±65.5秒、辐射剂量2.47±1.03 mSv。作者认为胸部CT为取栓转诊患者提供了一种务实、快速的COVID-19风险分层工具,纳入标准化区域卒中影像方案可高效利用医院资源且对整体治疗安排影响最小。
要点
- 胸部CT用于COVID-19筛查的阴性预测值为100%,敏感度为100%,有助于排除感染。
- 增加胸部CT平均额外耗时184±65.5秒,辐射剂量2.47±1.03 mSv。
- 胸部CT可发现具有临床意义的心血管和肺部偶然发现。
关键影像表现/征象
- 2例患者具有典型COVID-19影像学特征且检测阳性,7例患者影像学表现不确定但检测阴性,其余患者影像正常或为非典型改变,未被诊断或怀疑COVID-19。
- 在患者群体中发现了多个具有临床意义的心血管和肺部偶然发现。
诊断标准与关键数值
- 以实时逆转录聚合酶链反应检测为参考,胸部CT诊断COVID-19的总体敏感度为100%、特异度为74.1%、阴性预测值为100%、阳性预测值为22.2%。
- 胸部CT平均额外时间为184±65.5秒,平均额外辐射剂量为2.47±1.03 mSv。
临床应用与阅片要点
- 在急性缺血性卒中取栓转诊流程中,胸部CT可作为COVID-19风险分层的快速附加筛查工具。
- 胸部CT阴性预测值为100%,有助于在疫情期排除COVID-19感染。
- 阅片时需关注胸部CT上具有临床意义的心血管和肺部偶然发现。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Chest CT is a rapid, useful additional screening tool for coronavirus disease 2019 (COVID-19) in emergent procedures. We describe the feasibility and interim outcome of implementing a modified imaging algorithm for COVID-19 risk stratification across a regional network of primary stroke centers in the work-up of acute ischemic stroke referrals for time-critical mechanical thrombectomy.
MATERIALS AND METHODS: We undertook a retrospective review of 49 patients referred to the regional neuroscience unit for consideration of mechanical thrombectomy between April 14, 2020, and May 21, 2020. During this time, all referring units followed a standard imaging protocol that included a chest CT in addition to a head CT and CT angiogram to identify Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) infective pulmonary changes.
RESULTS: Overall, 2 patients had typical COVID-19 radiologic features and tested positive, while 7 patients had indeterminate imaging findings and tested negative. The others had normal or atypical changes and were not diagnosed with or suspected of having COVID-19. There was an overall sensitivity of 100%, specificity of 74.1%, negative predictive value of 100%, and positive predictive value of 22.2% when using chest CT to diagnose COVID-19 in comparison with the real-time reverse transcriptase-polymerase chain reaction test. The mean additional time and radiation dose incurred for the chest CT were 184 ± 65.5 seconds and 2.47 ± 1.03 mSv. Multiple cardiovascular and pulmonary incidental findings of clinical relevance were identified in our patient population.
CONCLUSIONS: Chest CT provides a pragmatic, rapid additional tool for COVID-19 risk stratification among patients referred for mechanical thrombectomy. Its inclusion in a standardized regional stroke imaging protocol has enabled efficient use of hospital resources with minimal compromise or delay to the overall patient treatment schedule.
引用
- Dhillon PS, Pointon K, Lenthall R, et al. Regional Mechanical Thrombectomy Imaging Protocol in Patients Presenting with Acute Ischemic Stroke during the COVID-19 Pandemic. AJNR Am J Neuroradiol. 2020. PMID: 32819897. doi:10.3174/ajnr.A6754
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。